Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Reco
United States
- New York
- 03/06/2022
- Series A
- $30,000,000
Our mission is to enable secure collaboration at the speed of business.
We believe that cloud collaboration tools have fundamentally changed the way modern organizations create business value. Attempting to secure these tools with techniques that were developed for legacy on-premise systems restricts collaboration, and misses a broad range of security events. Only by understanding the complete business context of an interaction, can security analysts identify, interpret, and determine the best way to respond to potential threats. Reco provides this business context.
- Industry Software Development
- Website https://reco.ai/
- LinkedIn https://www.linkedin.com/company/recolabs/
Related People
Gal NakashCo Founder
Israel -
ND
Active and motivated professional with a proven record of generating and building innovative research groups, managing research and projects from idea to completion, designing educational training, and coaching individuals to success. Responsible for technical strategy, risk management, and critical decision making. Experienced in all aspects of business development, including operations, finance, technology, and co-operations with partners.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)